Searchable abstracts of presentations at key conferences in endocrinology

ea0029p688 | Diabetes | ICEECE2012

Insulin protocol for hospital management of diabetes: a retrospective evaluation one year after the implementation

Garcia Torres F. , Valdes S. , Gonzalez-Molero I. , Gonzalo Marin M. , Rubio I. , Garcia Arnes J. , Munoz A. , Olveira G. , Ruiz de Adana M. , Soriguer F.

Introduction: Protocols for identifing and managing hyperglycemia and diabetes in hospital are necessary. Glycemic goals in non critical inpatients are:140 mg/ml(preprandial) and 180(posprandial),oral antidiabetic drug(OADs) withdrawn, avoid hypoglycemias, basal/bolus insulin (nor sliding scale) and request glycosylated haemoglobin.Aims: To evaluate the implementation of a protocol for management of diabetes(PHD) during the years 2009 and 2010 in our Hos...

ea0029p880 | Endocrine tumours and neoplasia | ICEECE2012

Neuroendocrine tumors of the gastrointestinal tract: a descriptive study

Leon de Zayas B. , del Olmo Garcia M. , Ramos Prol A. , Argente Pla M. , Munoz Vicente M. , Gilsanz Peral A. , Merino Torres J.

Introduction and objective: Neuroendocrine tumors (NETs) are relatively rare tumors. The majority are located in the gastrointestinal (GI) tract and bronchopulmonary system. The aim of this report is to study the characteristics of gastrointestinal NETs at diagnosis.Material and methods: Descriptive study about 18 patients diagnosed of gastrointestinal NETs during 1993–2011 in our hospital. Data regarding demographic, clinical, analytical, anatomopa...

ea0016p487 | Obesity | ECE2008

Bariatric surgery for patients whit morbid obesity: a cohort study

Antolin Sandra Herranz , Pelayo Miriam Perez , Losada Tomas Gonzalez , de Dios Luis Munoz , Tudanca Sergio Fuentes , Garcia Dolores del Olmo , Echarri Jaime Vazquez

Objectives: Analyze the evolution of body mass index (BMI) and percentage of excess weight loss (PEWL) after bariatric surgery; compare adjustable gastric banding (LABG) vs laparoscopic gastric bypass (LGB).Methods: Cohort study. Inclusion criteria: all cases underwent laparoscopic bariatric surgery; n=89; 9 patients were excluded for incomplete follow up. Differences between the 2 groups were evaluated using the Student t-test; P&#6...

ea0016p716 | Thyroid | ECE2008

Effects on bone mineral density of supraphysiological levothyroxine doses in patients with differentiated thyroid carcinoma

Mollar-Puchades Miguel Angel , Perez-Lazaro Antonia , Merino-Torres Juan Francisco , Munoz-Vicente Monica , Segovia-Portoles Raquel , Campos-Alborg Vicente , Navas-de Solis Ma Soledad , Pinon-Selles Francisco

Introduction: The treatment of differentiated thyroid carcinoma exposes most patients to chronic supraphysiological doses of thyroid hormone which seems to have several negative effects for the patient. The goal of the present study was to assess the consequences of these doses on the bone mineral density (BMD).Patients and methods: We performed a cross-sectional study on 64 female patients followed up between 1972 and 2007. We registered the levothyroxi...

ea0056p16 | Adrenal cortex (to include Cushing's) | ECE2018

Rare incidence of primary adrenocortical carcinosarcoma: a case report

Maria Diaz Perdigones Cristina , Maria Cornejo Pareja Isabel , Damas Fuentes Miguel , Molina Vega Maria , Hernandez Garcia Carmen , Munoz Garach Araceli , Jose Tinahones Madueno Francisco

Introduction: Adrenal tumors are common tumors with a prevalence of around 3% in a population over the age of 50 years. In contrast, adrenocortical carcinoma (ACC) is a rare malignancy (incidence 1–2 per 1 million population) with a heterogeneous presentation and a variable but generally bad prognosis. Patients present with evidence of adrenal steroid hormone excess in approximately 60% of cases.Case report: A 49-year-old woman with symptoms of faci...

ea0056p152 | Neuroendocrinology | ECE2018

Head and neck paragangliomas: genetic mutation and location of the tumors

Recio-Cordova Jose-Maria , Higueruela Cecilia , Caceres Rocio , Garcia-Duque Maria , Gonzalez-Sarmiento Rogelio , Miralles Jose-Manuel , Corrales-Hernandez Juan-Jose , Munoz-Herrera Angel

Introduction: Tumors derived from the paraganglionic system are rare. 90% of them are located on the adrenal gland, and the remaining 10% are extra-adrenal. Within this last group, 85% are located in the abdomen, 12% in the thorax, and 3% in the head and neck region (HNPG). Its proximity to important structures represents a great difficulty for resection. This makes it necessary to refer these patients to reference centers with multidisciplinary teams and specific surgical tra...

ea0056p300 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Treatment adherence through an Integral Care Program for patients with Metabolic Syndrome in Central Mexico

Munoz-Lopez Daniela Beatriz , Ramos-Borja David , Espino-Reyes Marisol , Reyes-Perez Veronica , Preciado-Puga Monica del Carmen , Gonzalez-Yebra Ana Lilia , Quintana-Vargas Silvia

Introduction: The Metabolic Syndrome (MS) is a cluster of risk factors that are related to cardiovascular disease. In Mexico, the prevalence of MS in adults according to the ENSANUT 2012 is 41%, and it has become a public health problem making it necessary to implement strategies for its management at the lowest cost possible that could encourage adherence to treatment.Objective: To evaluate the effectiveness of a comprehensive care program to achieve an...

ea0056p304 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Efficacy and safety of proprotein convertase subtilisin/kexintype nine inhibitors in real life experience

Navarro-Hoyas Clara , Moragrega Raquel Miralles , Delegido-Gomez Laura , Lopez-Munoz Beatriz , Moreno-Perez Oscar , Pico-Alfonso Antonio , Gonzalez-Sanchez Victor

Introduction: PCSK9 inhibitors (iPCSK9) have previously been evaluated through controlled clinical trials showing up to 60% reduction in LDL cholesterol concentrations. However, we still do not have enough data regarding the real life experience of the treatment.Objectives: 1) Describe patients with hypercholesterolemia treated with iPCSK9 in clinical practice.2) Evaluate treatment efficacy and safety.Methods...

ea0056p481 | Diabetes therapy | ECE2018

Perinatal outcomes in Mexican women with mild gestational diabetes mellitus without treatment diagnosed by the international association of diabetes and pregnancy study groups criteria

Martinez Cruz Nayeli , Reyes Munoz Enrique , Soriano Ortega Karla P. , Arce Sanchez Lidia , Ortega Gonzalez Carlos , Torres Herrera Ursula , Espino y Sosa Salvador , Montoya Estrada Aracely

Aims: To compare the risk of adverse perinatal outcomes (APO) between pregnant women with mild gestational diabetes mellitus (GDM) by International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria without treatment versus women without GDM.Methods: A retrospective cohort study. We included pregnant women with prenatal care and delivery at our Institution. Group 1, women with mild GDM defined by one abnormal glucose value according to ...

ea0056p490 | Diabetes therapy | ECE2018

Experience in clinical practice with new long-acting insulins in type 2 diabetes (T2D)

Vega Maria Molina , Garach Araceli Munoz , Fuentes Miguel Damas , Garcia Carmen Hernandez , Perdigones Cristina Diaz , Pareja Isabel Cornejo , Madueno Francisco Tinahones

Introduction: New long-acting insulin analogues (insulin degludec –ID- and insulin glargine 300 U/ml –IG300-) have proved, in clinical trials, that improve metabolic control with lower hypoglycemia rate in T2D.Objective: To assess characteristics of T2D patients who were given ID and IG300 and to evaluate their effect on metabolic control, weight and insulin dose.Material and methods: We studied T2D patients whose treatme...